Evermay Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Evermay Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.32K	Hold	216	–	–	﹤0.01%	537
2026 Q1	$6.51K	Hold	216	–	–	﹤0.01%	492
2025 Q4	$6.74K	Hold	216	–	–	﹤0.01%	472
2025 Q3	$4.36K	Hold	216	–	–	﹤0.01%	477
2025 Q2	$3.62K	Hold	216	–	–	﹤0.01%	484
2025 Q1	$3.32K	Buy	+216	New	+$3.86K	﹤0.01%	499

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Evermay Wealth Management's TEVA Position: Q2 2026 in Review

Evermay Wealth Management held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q2 2026 at 216 shares worth $7.32K. The position accounts for ﹤0.01% of the portfolio, ranked #537.

Evermay Wealth Management first reported a position in TEVA in Q1 2025 and has held it in 6 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Evermay Wealth Management held 216 shares of Teva Pharmaceutical Industries Limited worth $7.32K as of Q2 2026.
Evermay Wealth Management left its Teva Pharmaceutical Industries Limited share count unchanged in Q2 2026.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Evermay Wealth Management's portfolio in Q2 2026, its #537 holding.
Evermay Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2025 and has held it in 6 quarters since.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Evermay Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.